PURPOSE: To characterize seizure outcomes following temporal lobe epilepsy (TLE) surgery in patients with normal preoperative brain magnetic resonance imaging (MRI). METHODS: We reviewed adult patients with pharmacoresistant epilepsy and normal MRI who underwent TLE surgery (1996-2009). Seizure outcomes were analyzed using survival and multivariate regression with Cox proportional hazard modeling. Two analyses were performed using two favorable outcome definitions: complete seizure freedom and Engel classification. KEY FINDINGS: Sixty-four patients were analyzed (mean follow-up 4.1 years; range 1-14.5 years). Most had a standard anterior temporal lobectomy (84%) and unremarkable pathology (45%). At 1 year, the chance of complete seizure freedom was 76% [95% confidence interval (CI) 71-81%] comparable to an 81% (95% CI 76-86%) chance of Engel score of 1. With longer follow-up, a progressively broadening significant discrepancy between the two outcome measures was observed. The chance of complete seizure freedom was 66% (95% CI 61-71%) at 2 years, and 47% (95% CI 40-54%) at 7 years and beyond, whereas the respective chances of achieving an Engel 1 classification were 76% (95% CI 70-82%), and 69% (95% CI 63-75%) at similar time points. Seizure outcome as defined by either measure was worse in patients with higher baseline seizure frequency (adjusted risk-ratio 2.7 when >12 seizures/month; p = 0.01) and with preoperative generalized tonic-clonic seizures (adjusted risk ratio 10.8; p = 0.0006). Memory measures declined with dominant hippocampus resections. SIGNIFICANCE: A normal MRI should not prevent presurgical evaluations in patients with suspected TLE, as favorable long-term postoperative seizure outcomes are possible. Proposed mechanisms of epileptogenicity and seizure recurrence in this group are discussed. Wiley Periodicals, Inc.
PURPOSE: To characterize seizure outcomes following temporal lobe epilepsy (TLE) surgery in patients with normal preoperative brain magnetic resonance imaging (MRI). METHODS: We reviewed adult patients with pharmacoresistant epilepsy and normal MRI who underwent TLE surgery (1996-2009). Seizure outcomes were analyzed using survival and multivariate regression with Cox proportional hazard modeling. Two analyses were performed using two favorable outcome definitions: complete seizure freedom and Engel classification. KEY FINDINGS: Sixty-four patients were analyzed (mean follow-up 4.1 years; range 1-14.5 years). Most had a standard anterior temporal lobectomy (84%) and unremarkable pathology (45%). At 1 year, the chance of complete seizure freedom was 76% [95% confidence interval (CI) 71-81%] comparable to an 81% (95% CI 76-86%) chance of Engel score of 1. With longer follow-up, a progressively broadening significant discrepancy between the two outcome measures was observed. The chance of complete seizure freedom was 66% (95% CI 61-71%) at 2 years, and 47% (95% CI 40-54%) at 7 years and beyond, whereas the respective chances of achieving an Engel 1 classification were 76% (95% CI 70-82%), and 69% (95% CI 63-75%) at similar time points. Seizure outcome as defined by either measure was worse in patients with higher baseline seizure frequency (adjusted risk-ratio 2.7 when >12 seizures/month; p = 0.01) and with preoperative generalized tonic-clonic seizures (adjusted risk ratio 10.8; p = 0.0006). Memory measures declined with dominant hippocampus resections. SIGNIFICANCE: A normal MRI should not prevent presurgical evaluations in patients with suspected TLE, as favorable long-term postoperative seizure outcomes are possible. Proposed mechanisms of epileptogenicity and seizure recurrence in this group are discussed. Wiley Periodicals, Inc.
Authors: Karen Blackmon; William B Barr; Chris Morrison; William MacAllister; Michelle Kruse; Christina Pressl; Xiuyuan Wang; Patricia Dugan; Anli A Liu; Eric Halgren; Orrin Devinsky; Thomas Thesen Journal: Epilepsy Behav Date: 2019-06-07 Impact factor: 2.937
Authors: Dario J Englot; Kunal P Raygor; Annette M Molinaro; Paul A Garcia; Robert C Knowlton; Kurtis I Auguste; Edward F Chang Journal: Neurosurgery Date: 2014-12 Impact factor: 4.654
Authors: David B Burkholder; Vlastimil Sulc; E Matthew Hoffman; Gregory D Cascino; Jeffrey W Britton; Elson L So; W Richard Marsh; Fredric B Meyer; Jamie J Van Gompel; Caterina Giannini; C Thomas Wass; Robert E Watson; Gregory A Worrell Journal: JAMA Neurol Date: 2014-06 Impact factor: 18.302
Authors: William H Theodore; Ashley R Martinez; Omar I Khan; Clarissa J Liew; Sungyoung Auh; Irene M Dustin; John Heiss; Susumu Sato Journal: J Nucl Med Date: 2012-07-10 Impact factor: 10.057
Authors: Wesley T Kerr; Xingruo Zhang; Chloe E Hill; Emily A Janio; Andrea M Chau; Chelsea T Braesch; Justine M Le; Jessica M Hori; Akash B Patel; Corinne H Allas; Amir H Karimi; Ishita Dubey; Siddhika S Sreenivasan; Norma L Gallardo; Janar Bauirjan; Eric S Hwang; Emily C Davis; Shannon R D'Ambrosio; Mona Al Banna; Andrew Y Cho; Sandra R Dewar; Jerome Engel; Jamie D Feusner; John M Stern Journal: Seizure Date: 2021-02-09 Impact factor: 3.184
Authors: Maarten Haemels; Donatienne Van Weehaeghe; Evy Cleeren; Patrick Dupont; Johan van Loon; Tom Theys; Koen Van Laere; Wim Van Paesschen; Karolien Goffin Journal: Acta Neurol Belg Date: 2021-02-05 Impact factor: 2.396